Literature DB >> 18437043

Progressive cerebellar ataxia with variable episodic symptoms--phenotypic diversity of R1668W CACNA1A mutation.

Sarah Marti1, Robert W Baloh, Joanna C Jen, Dominik Straumann, Hans H Jung.   

Abstract

We describe a family with an R1668W mutation in the CACNA1A gene who presented with a broader clinical spectrum and more variable features than previously reported. The mother had a pure progressive cerebellar ataxia of late onset with downbeat nystagmus, whereas her daughter suffered from episodic ataxia, hemiplegic migraine, and progressive cerebellar ataxia with horizontal gaze-evoked and rebound nystagmus. In both patients, treatment with acetazolamide was ineffective and worsened baseline ataxia, whereas flunarizine ameliorated episodic symptoms. Our report highlights profound phenotypic variability that can be associated with CACNA1A mutations and adds important therapeutic considerations. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437043     DOI: 10.1159/000127974

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  Case Report: A Novel CACNA1A Mutation Caused Flunarizine-Responsive Type 2 Episodic Ataxia and Hemiplegic Migraine With Abnormal MRI of Cerebral White Matter.

Authors:  Xiaoqiu Yuan; Yiming Zheng; Feng Gao; Wei Sun; Zhaoxia Wang; Guiping Zhao
Journal:  Front Neurol       Date:  2022-05-23       Impact factor: 4.086

2.  Complex effects on CaV2.1 channel gating caused by a CACNA1A variant associated with a severe neurodevelopmental disorder.

Authors:  Benjamin J Grosso; Audra A Kramer; Sidharth Tyagi; Daniel F Bennett; Cynthia J Tifft; Precilla D'Souza; Michael F Wangler; Ellen F Macnamara; Ulises Meza; Roger A Bannister
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

3.  A novel de novo pathogenic mutation in the CACNA1A gene.

Authors:  Shinsuke Fujioka; Sruti Rayaprolu; Christina Sundal; Daniel F Broderick; William A Langley; John Shoffner; Lauren C Hyams; Rosa Rademakers; Neill R Graff-Radford; William Tatum; Owen A Ross; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 4.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.